Nutex Health Files 8-K Under 'Other Events'
Ticker: NUTX · Form: 8-K · Filed: Sep 10, 2025 · CIK: 1479681
| Field | Detail |
|---|---|
| Company | Nutex Health, INC. (NUTX) |
| Form Type | 8-K |
| Filed Date | Sep 10, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: other-events, filing-update
Related Tickers: NUTX
TL;DR
NUTX filed an 8-K for 'Other Events' on 9/10, event date 9/8. Details TBD.
AI Summary
Nutex Health, Inc. filed an 8-K on September 10, 2025, reporting an event on September 8, 2025. The filing is categorized under 'Other Events' and does not provide specific details on the nature of the event, dollar amounts, or names involved.
Why It Matters
This filing indicates a material event has occurred for Nutex Health, Inc., requiring disclosure to investors, though the specific details are not yet provided.
Risk Assessment
Risk Level: medium — The filing is under 'Other Events' without immediate detail, creating uncertainty for investors about the nature and impact of the reported event.
Key Players & Entities
- Nutex Health, Inc. (company) — Registrant
- September 8, 2025 (date) — Earliest event reported
- September 10, 2025 (date) — Filing date
- Clinigence Holdings, Inc. (company) — Former company name
- iGambit, Inc. (company) — Former company name
FAQ
What specific event is Nutex Health, Inc. reporting under 'Other Events'?
The filing does not specify the nature of the 'Other Events' beyond categorizing it as such.
When did the event that prompted this 8-K filing occur?
The earliest event reported occurred on September 8, 2025.
On what date was this 8-K filing submitted to the SEC?
The filing was submitted on September 10, 2025.
What is Nutex Health, Inc.'s principal executive office address?
The principal executive offices are located at 6030 S. Rice Ave., Suite C, Houston, Texas 77081.
Has Nutex Health, Inc. undergone any previous name changes?
Yes, the company was formerly known as Clinigence Holdings, Inc. (name change effective 20191113) and iGambit, Inc. (name change effective 20091230).
Filing Stats: 544 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2025-09-10 16:16:23
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value NUTX NASDAQ Capital Market
Filing Documents
- nutx-20250908.htm (8-K) — 21KB
- 0001479681-25-000077.txt ( ) — 136KB
- nutx-20250908.xsd (EX-101.SCH) — 2KB
- nutx-20250908_lab.xml (EX-101.LAB) — 22KB
- nutx-20250908_pre.xml (EX-101.PRE) — 13KB
- nutx-20250908_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On September 8, 2025, a purported stockholder filed a derivative action (the "Derivative Action") on behalf of Nutex Health Inc. (the "Company") in the United States District Court for the Southern District of Texas, captioned Juan Camilo Jimenez, derivatively on behalf of Nutex Health Inc ., Case No. 4:25-cv-04253, naming as defendants the Company's Chief Executive Officer, its Chief Financial Officer and its President, along with the current members of its Board of Directors (other than Frank E. Jaumot) and a director who recently retired from the Board of Directors, alleging, among other things, violations of Section 14(a) of the Securities Exchange Act of 1934 (the "Exchange Act"), breaches of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets. The Derivative Action seeks orders permitting the plaintiff to maintain the action derivatively on behalf of the Company, awarding unspecified damages allegedly sustained by the Company, awarding restitution from the individual defendants and requiring the Company to make certain reforms to its corporate governance and internal procedures. At this stage, the Company is unable to predict the outcome of the litigation or estimate the potential financial impact, if any. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Date: September 10, 2025 Nutex Health Inc. By: /s/ Jon C. Bates Jon C. Bates Chief Financial Officer